SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to a recent reverse split and resulting small float, leading to high volatility and discussions of potential short squeezes. The community is comparing TGL to other high-flying stocks like $SMX, with some anticipating a similar explosive run. Bullish sentiment is fueled by the company's shift towards fintech and AI, with potential catalysts including new product rollouts and partnership announcements.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a massive, rapid price surge, sparking intense debate about a potential short squeeze and its sustainability. The community is buzzing with discussions around high volatility, potential for further gains, and comparisons to other high-flying stocks. Some traders caution against chasing the rally, while others remain bullish, citing the low float and potential for continued upward momentum.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix ($NFLX) is trending amid news of acquiring Warner Bros. Discovery, a move sparking mixed reactions; some investors worry about debt and regulatory hurdles, while others see long-term dominance in streaming. Community chatter revolves around the deal's potential impact on content, subscription costs, and the competitive landscape with rivals like Disney. Some traders are betting on short-term volatility, while others remain bullish on $NFLX's expanded content library.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Wheeler Real Estate Investment Trust Inc

WHLR is trending amid community speculation of a potential short squeeze, drawing comparisons to SMX due to its low float and high short interest. The stock's significant pre-market gains and subsequent volatility have fueled discussions about possible price targets and trading strategies, with some traders highlighting the company's asset value relative to its market cap. However, caution is advised due to the company's history of reverse splits and potential dilution.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Traders are actively discussing Adobe's ($ADBE) recent performance, with some citing technical indicators suggesting a bullish trend, while others express frustration with the stock's inability to sustain gains. Community sentiment appears mixed amidst discussions around AI competition, potential undervaluation, and upcoming earnings. Chatter includes opinions on management, potential acquisitions, and speculation on future price movements.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake ($SNOW) is trending amid discussions around its Q3 earnings, with the stock experiencing significant volatility and high trading volume. Community chatter is focused on whether strong AI partnerships and momentum can offset margin concerns, with some traders betting on a rally while others anticipate further declines. Analysts are weighing in with price target adjustments, and the stock's reaction is being compared to peers in the software and AI space.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss the potential for a buyout or strategic partnership, fueled by promising data in lung, prostate, and pancreatic cancers. Community talking points center on the company being significantly undervalued with a large short interest, positioning it for a potential squeeze.  LOAD!

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending amid speculation of a short squeeze, fueled by investor Martin Shkreli's bullish stance and a $100 near-term price target. The community is actively discussing the company's potential in photonics and comparing it to recent high-flying stocks like $SMX. With high volume and rising interest, traders are closely watching for continued upward momentum.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne's shares are trending despite a strong earnings beat, with community discussion focused on the disconnect between performance and stock price. Analysts are updating ratings, and some investors are optimistic about a rebound and long-term call options, while others express concern over declining gross profit margins and guidance. Acquisition potential remains a key talking point amid the revenue growth.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses its potential breakout and compares its chart to other cryptos. Talk centers on Litecoin's stability, historical performance, and potential for significant gains. Comparisons to Bitcoin and other altcoins are being made, with some highlighting Litecoin's transactional value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SIBN Heads up alert! Only three days until Upcoming earnings on Monday, 8/4/2025 for $SIBN 
Neutral (5.3) 
 
### SI-BONE, Inc. 
Financial Analysis 
 
SI-BONE, Inc. 
(NASDAQ: SIBN) has demonstrated a commendable performance with its shareholders enjoying an 8.6% compound annual growth rate (CAGR) over the last three years, indicating a stable upward trajectory in shareholder value. 
As a medical device company focusing on sacropelvic disorders, SI-BONE is strategically positioned in a niche market with promising growth prospects. 
The company&#39;s P/E ratio remains competitive within the industry, suggesting that its current stock price is reasonably aligned with its earnings. 
This reflects market confidence in its business model and future earnings potential. 
The EPS growth has shown positive momentum, which is a critical indicator of the company&#39;s profitability and operational efficiency. 
Furthermore, SI-BONE&#39;s revenue forecasts suggest a robust upward trend, driven by increased adoption of its innovative solutions and expansion into new markets. 
When compared to industry peers, SI-BONE maintains a strong position, leveraging its specialized focus and innovative product offerings to capture market share and enhance revenue streams. 
### Upcoming Earnings Report 
 
SI-BONE is set to release its second-quarter financial results on August 4, 2025. 
Historically, the company has consistently met or exceeded analyst expectations, which has contributed to its favorable market perception. 
Analyst consensus estimates for the upcoming earnings report indicate a positive outlook, with expectations of continued revenue growth and sustained profitability. 
The anticipated financial performance is likely to have a significant impact on the stock, as investors will be keen to assess the company&#39;s ability to maintain its growth trajectory and capitalize on emerging opportunities in the sacropelvic disorder treatment market. 
### Sector Performance 
 
SI-BONE operates within the medical device sector, which has exhibited robust performance in recent times. 
The sector is characterized by ongoing innovation, regulatory developments, and a strong demand for advanced medical solutions. 
Despite macroeconomic challenges, the sector has shown resilience, supported by an aging population and increasing healthcare expenditures. 
SI-BONE, with its focused niche and innovative approach, is well-positioned to benefit from the sector&#39;s growth dynamics, enhancing its potential to deliver long-term value to shareholders. 
 
- Funds were net buyers of $SIBN during the previous reporting quarter. 
 
- Funds with large holdings in $SIBN include: 
 
- OrbiMed Advisors LLC, MV: $48MM. Fund Rank: 55% 
www.orbimed.com 
- First Light Asset Management LLC, MV: $23MM. Fund Rank: 55% 
www.firstlightam.com 
- Granahan Investment Management Inc, MV: $20MM. Fund Rank: 70% 
www.granahan.com 
- Holocene Advisors LP, MV: $8MM. Fund Rank: 92% 
www.holoceneadvisors.com 
- Pier Capital LLC, MV: $7MM. Fund Rank: 63% 
www.piercap.com 
- Last 10 days performance: -1% 
- Last 30 days performance: -8% 
- Last 90 days performance: 22% 
 
Some of the latest news articles: 
 - Title: SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 
Publication Date: 7/29/2025 8:30:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/si-bone-present-canaccord-genuity-203000440.html?.tsrc=rss 
 
 - Title: SI-BONE (NASDAQ:SIBN) shareholders have earned a 8.6% CAGR over the last three years 
Publication Date: 7/29/2025 1:42:16 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/si-bone-nasdaq-sibn-shareholders-134216181.html?.tsrc=rss 
 
 - Title: SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025 
Publication Date: 7/14/2025 8:09:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/si-bone-report-second-quarter-200900479.html?.tsrc=rss 
 
Follow us on stocktwits.com and Substack (chessgmstocks.substack.com). Not a financial advice. Not a trading signal.

OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes. From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.

Orbimed

OrbiMed

Specialized &Diversified We invest exclusively in health care and across its industries: Biotech * Medical Devices & Equipment Health Care IT * Specialty Pharma Diagnostic Tools & Services Life Science Tools & Services Health Care Services Differentiated We primarily seek out less-crowded names within micro- to mid-cap stocks that often are inefficiently priced.

First Light Asset Management - Matt Arens

Home - First Light Asset Management - Matt Arens

Granahan Investment Management (GIM) is a US-based, boutique asset manager that specializes in investing in Small and Mid Cap Growth companies on behalf of Institutional Investors since 1985.

Granahan

Home - Granahan

Holocene is an investment management firm driven to deliver superior risk-adjusted returns through rigorous research, sophisticated risk management and advanced quantitative tools. We bring together top-tier talent to pursue two equity investment strategies: a sector-diversified long/short strategy and a concentrated long-only strategy.

Holocene

Pier Capital, LLC

Pier Capital, LLC Home

SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, August 12, 2025, at 12:00 p.m.

Yahoo Finance

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

Buying a low-cost index fund will get you the average market return. But across the board there are plenty of stocks...

SI-BONE (NASDAQ:SIBN) shareholders have earned a 8.6% CAGR over the last three years

SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 after market close on Monday, August 4, 2025. Management will host a conference call beginning at 1:30 p.m.

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Stocktwits

Stocktwits - Stock Market Live Quotes, Social Community Discussions, News, Stock Rankings & Earnings

We are full-time investors. We use AI, prop tech, and data to make predictive stock trade decisions. We aim to make an educated call based on data. We do not provide a trading signal nor do we offer a financial advice. Please do your own DD.

Substack

EDGR's Substack | ChessGM | Substack

StockTwits Web

SI-BONE Inc

 Heads up alert! Only three days until Upcoming earnings on Monday, 8/4/2025 for 

 
Neutral (5.3) 
 
### SI-BONE, Inc. 
Financial Analysis 
 
SI-BONE, Inc. 
(NASDAQ: SIBN) has demonstrated a commendable performance with its shareholders enjoying an 8.6% compound annual growth rate (CAGR) over the last three years, indicating a stable upward trajectory in shareholder value. 
As a medical device company focusing on sacropelvic disorders, SI-BONE is strategically positioned in a niche market with promising growth prospects. 
The company's P/E ratio remains competitive within the industry, suggesting that its current stock price is reasonably aligned with its earnings. 
This reflects market confidence in its business model and future earnings potential. 
The EPS growth has shown positive momentum, which is a critical indicator of the company's profitability and operational efficiency. 
Furthermore, SI-BONE's revenue forecasts suggest a robust upward trend, driven by increased adoption of its innovative solutions and expansion into new markets. 
When compared to industry peers, SI-BONE maintains a strong position, leveraging its specialized focus and innovative product offerings to capture market share and enhance revenue streams. 
### Upcoming Earnings Report 
 
SI-BONE is set to release its second-quarter financial results on August 4, 2025. 
Historically, the company has consistently met or exceeded analyst expectations, which has contributed to its favorable market perception. 
Analyst consensus estimates for the upcoming earnings report indicate a positive outlook, with expectations of continued revenue growth and sustained profitability. 
The anticipated financial performance is likely to have a significant impact on the stock, as investors will be keen to assess the company's ability to maintain its growth trajectory and capitalize on emerging opportunities in the sacropelvic disorder treatment market. 
### Sector Performance 
 
SI-BONE operates within the medical device sector, which has exhibited robust performance in recent times. 
The sector is characterized by ongoing innovation, regulatory developments, and a strong demand for advanced medical solutions. 
Despite macroeconomic challenges, the sector has shown resilience, supported by an aging population and increasing healthcare expenditures. 
SI-BONE, with its focused niche and innovative approach, is well-positioned to benefit from the sector's growth dynamics, enhancing its potential to deliver long-term value to shareholders. 
 
- Funds were net buyers of 

 during the previous reporting quarter. 
 
- Funds with large holdings in 

 include: 
 
- OrbiMed Advisors LLC, MV: $48MM. Fund Rank: 55% 


 
- First Light Asset Management LLC, MV: $23MM. Fund Rank: 55% 


 
- Granahan Investment Management Inc, MV: $20MM. Fund Rank: 70% 


 
- Holocene Advisors LP, MV: $8MM. Fund Rank: 92% 


 
- Pier Capital LLC, MV: $7MM. Fund Rank: 63% 


 
- Last 10 days performance: -1% 
- Last 30 days performance: -8% 
- Last 90 days performance: 22% 
 
Some of the latest news articles: 
 - Title: SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 
Publication Date: 7/29/2025 8:30:00 PM, Source: yahoo 
URL: 

 
 
 - Title: SI-BONE (NASDAQ:SIBN) shareholders have earned a 8.6% CAGR over the last three years 
Publication Date: 7/29/2025 1:42:16 PM, Source: yahoo 
URL: 

 
 
 - Title: SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025 
Publication Date: 7/14/2025 8:09:00 PM, Source: yahoo 
URL: 

). Not a financial advice. Not a trading signal.